© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Name: Haloperidol
Chemical Formula: C21H23ClFNO2
Description: Haloperidol is a typical antipsychotic agent used in the management of schizophrenia, acute psychosis, and Tourette's disorder. It is often found as a white to slightly yellow crystalline powder. The compound gives off practically no distinct odor. People handling this substance in labs, manufacturing, or pharmacy settings have direct encounters with this chemical, which underscores the roles of material safety understanding and precautions.
Acute Risks: Skin and eye irritation, respiratory tract irritation, central nervous system depression, risk of arrhythmia at higher doses.
GHS Symbols: Exclamation mark (irritant), Health hazard symbol for specific organ toxicity.
Routes of Exposure: Inhalation, skin contact, ingestion, incidental eye contact. Many chemists, pharmacists, or janitorial staff deal with these risks, often without much notice while rushing daily tasks.
Potential Symptoms: Headache, dizziness, drowsiness, dry mouth, muscle stiffness, irregular heartbeat. These effects are well documented and have prompted many facilities to enforce stricter engineering controls.
Chronic Effects: Prolonged exposure, even at low concentrations, connects to nervous system symptoms, which could hit people working with bulk powders or repeated spills.
Active Ingredient: Haloperidol
CAS Number: 52-86-8
Purity: Often ranges above 98% for pharmaceutical-grade material. Impurities, while minor, do not usually become a major safety concern but remain on analytical reports.
Formulators: Add excipients or diluents for tablets/solutions, but pure haloperidol presents the greatest risk in raw manufacturing, compounding, or preparation labs.
Inhalation: Transfer the person to fresh air. Trained staff should provide oxygen if breathing becomes labored. Seek medical attention if symptoms persist or worsen.
Skin Contact: Wash with soap and water for at least 15 minutes. Remove contaminated clothing and wash before reuse. Most workers miss this step in a hurry, but unwashed skin increases risk of local and systemic effects.
Eye Contact: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy. Persistent eye discomfort requires rapid medical care, as vision can be impacted by chemical irritants.
Ingestion: Rinse mouth. If the victim is alert, water can dilute the effect. Never attempt to induce vomiting. Quick access to emergency care is vital, since swallowing haloperidol—even accidentally—leads to unwanted neurological and cardiac symptoms.
Extinguishing Media: Use water spray, alcohol-resistant foam, dry chemical, or carbon dioxide. The chemical is non-flammable, but combustion can release toxic fumes.
Hazards: Combustion produces hydrogen chloride, nitrogen oxides, carbon oxides, and possibly fluorinated compounds. Good ventilation limits workers’ exposure.
Protective Equipment: Firefighters should wear self-contained breathing apparatus and full protective gear because unrecognized inhalation risks pop up during cleanup of burning pharmaceuticals.
Personal Protection: Gloves, protective clothing, and safety goggles should be worn. Use respiratory protection if area is unventilated or if dust forms.
Spill Response: Cover powder spills with damp disposable towels, then wipe up gently to minimize dust. Containment prevents unnecessary spread.
Disposal: Place collected material in approved waste disposal containers. Avoid heavy-handed use of solvents which can increase mobility of hazardous compounds in the environment.
Decontamination: Clean spill area with standard laboratory disinfectant or soap and water solution. The process gets repeated frequently in production areas.
Safe Handling: Avoid inhaling dust, or contact with skin and eyes. Always work in a well-ventilated area, use protective equipment, and keep away from food and drink.
Hygiene: Wash hands and skin after handling. Facilities that fail in this area see higher workplace illness rates.
Storage: Store in tightly closed containers, in a cool, dry, and well-ventilated area. Keep away from acids and oxidizers. Refrigeration can extend shelf life, but most sites use ambient temperatures aligned with stability study results.
Segregation: Do not mix raw haloperidol storage with incompatible chemicals or general cleaning products.
Engineering Controls: Use workstations with local exhaust ventilation. Fume hoods reduce inhalation hazards.
Personal Protective Equipment: Gloves resistant to chemicals, lab coats, goggles, and, if dust is present, properly fitted NIOSH-approved respirators.
Handwashing: Facilities with readily available sinks see lower incident rates, making hand hygiene a simple but effective defense.
Monitoring: Exposure levels in work air should be measured periodically, especially during high-volume bulk handling shifts.
Occupational Limits: No established OSHA permissible exposure limits for haloperidol, but best practice relies on keeping exposure “as low as reasonably achievable,” which often triggers extra administrative controls.
Appearance: White to faint yellow crystalline powder.
Odor: Little to none, but the absence of smell offers no early warning for exposure.
Molecular Weight: 375.9 g/mol.
Melting Point: 150–152°C
Solubility: Poor in water, more soluble in organic solvents like chloroform and methanol.
Boiling Point: Data not readily available.
Flash Point: Data not readily available. Most handlers pay little attention here due to low risk, but modified settings might warrant checking when mixing with solvents.
pH: Data not available for solid powder; for solution, lab values fall around neutral.
Chemical Stability: Remains stable under recommended storage conditions. Improper handling, such as exposure to heat, light, or oxidizers, can degrade the compound.
Reactivity: Incompatible with strong oxidizing agents, strong acids, and bases. Mixing with these leads to possible decomposition or release of toxic gases.
Hazardous Decomposition Products: Carbon oxides, hydrogen chloride, fluorinated compounds may form during combustion or certain breakdown processes.
Acute Effects: Can cause central nervous system depression, rapid heartbeat, severe muscle rigidity, and, in rare events, sudden death by arrhythmia at relatively high doses. Inhalation or skin exposure during handling can cause sneaky onsets of these symptoms.
Chronic Toxicity: Long-term exposure or high levels can trigger extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome.
Target Organs: Central nervous system, cardiovascular system.
Routes of Exposure: Skin and eye contact, inhalation, accidental ingestion.
Cancer Risk: No conclusive evidence connects haloperidol directly to cancer, but animal studies at extreme doses point to some cautionary tales.
Persistence: Haloperidol can persist in the environment, especially in aquatic systems.
Bioaccumulation: Data suggests a low potential, but pharmaceuticals in waterways remain a growing concern worldwide as trace amounts affect aquatic life.
Toxicity to Aquatic Life: No definitive data exists on toxicity levels, but chronic discharge of psychotropic drugs causes behavioral changes in fish and other wildlife. Pharmaceutical plants or users dumping expired stock without care only increase the problem.
Degradability: Breakdowns occur over time, with slower rates in the absence of sunlight or microbial action.
Waste Disposal: Incineration in an approved facility remains the gold standard for pharmaceutical chemicals due to the resilient nature of haloperidol.
Never Pour Down Drain: Sewer disposal routes only escalate aquatic contamination. Solid waste landfills are inadequate without chemical stabilization.
Containers: Rinse and return empty containers for incineration or secure landfill, not standard trash. Cross-contaminated debris—like gloves or wipes—must follow hazardous waste pathways.
National Guidelines: Follow local, state, and national rules for hazardous medical waste, as variances in legal standards can trip up even the most diligent staff.
Regulations: Not classified as a dangerous good under most transportation rules, but firms dealing with large quantities consult IATA/IMDG/ADR standards to avoid unexpected customs seizures.
Packing: Double-bagging and robust containers cut risk of spills in transit.
Labeling: Proper chemical labeling is essential, given the penalties and risks of unmarked chemical shipments.
Emergency Measures: Transport vehicles should carry basic spill kits, as accidents during delivery have prompted entire pharmacy recalls in the past.
US Regulation: The FDA regulates haloperidol strictly as a prescription medication. OSHA general standards apply during manufacture, compounding, and research.
REACH and EU: Listed in Annex IV/V for exemption from registration for pharmaceuticals, but safety management is expected at all handling stages.
Workplace Standards: No Permissible Exposure Limits set by OSHA, but Hazard Communication Standards require proper documentation and staff information.
Recordkeeping: Document all significant handling, spills, and exposures. Training compliance audits continue to reveal gaps in pharmaceutical sites rushing to meet demand or onboarding new staff.
Hazard Symbols: Many facilities display GHS pictograms and warnings prominently to ensure staff awareness—an area where lapses quickly translate into health risks.
